CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 253 enrolled
Drug / intervention
senofilcon A TEST Lens +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03707821
NCT03707821N/ACompleted
CompareCT.gov

Design Validation of Senofilcon A With New UV-blocking Additive

Johnson & Johnson Vision Care, Inc.·interventional·Posted Oct 16, 2018·Updated Dec 5, 2019

In Brief

A clinical study evaluating senofilcon A TEST Lens and senofilcon A CONTROL Lens for Visual Acuity. Completed, enrolled 253 participants across 10 sites.

Detailed Summary

This is a 2-visit, multi-site, partially subject-masked, 2-arm parallel, controlled, randomized and dispensing trial. Subjects will be randomized to one of two study lenses for the entire duration of the study. The study lenses will be worn for a period of 2 weeks each in a bilateral fashion.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVisual Acuity
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedOct 16, 2018
Enrollment StartOct 1, 2018
Primary CompletionNov 1, 2018
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 7.7 years ago

Interventions

senofilcon A TEST Lensdevice

JJVC Investigational Contact Lens

senofilcon A CONTROL Lensdevice

Acuvue Oasys